567 related articles for article (PubMed ID: 16699371)
1. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
Liu S; Riley J; Rosenberg S; Parkhurst M
J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
3. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
[TBL] [Abstract][Full Text] [Related]
4. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
Rosenthal R; Groeper C; Bracci L; Adamina M; Feder-Mengus C; Zajac P; Iezzi G; Bolli M; Weber WP; Frey DM; von Holzen U; Oertli D; Heberer M; Spagnoli GC
J Immunother; 2009 Apr; 32(3):252-61. PubMed ID: 19242375
[TBL] [Abstract][Full Text] [Related]
5. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
[TBL] [Abstract][Full Text] [Related]
6. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.
Cantó E; Rodriguez-Sanchez JL; Vidal S
J Leukoc Biol; 2003 Dec; 74(6):998-1007. PubMed ID: 12972509
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
Lin SJ; Cheng PJ; Hsiao SS
Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
[TBL] [Abstract][Full Text] [Related]
8. IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells.
Liu K; Catalfamo M; Li Y; Henkart PA; Weng NP
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6192-7. PubMed ID: 11972069
[TBL] [Abstract][Full Text] [Related]
9. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
[TBL] [Abstract][Full Text] [Related]
10. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation.
Sereti I; Gea-Banacloche J; Kan MY; Hallahan CW; Lane HC
Clin Immunol; 2000 Dec; 97(3):266-76. PubMed ID: 11112366
[TBL] [Abstract][Full Text] [Related]
12. Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells.
Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
Hum Immunol; 2006 Nov; 67(11):874-83. PubMed ID: 17145367
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood.
Bofill M; Almirall E; McQuaid A; Peña R; Ruiz-Hernandez R; Naranjo M; Ruiz L; Clotet B; Borràs FE
Clin Exp Immunol; 2004 Dec; 138(3):460-5. PubMed ID: 15544623
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
Lin SJ; Chao HC; Chang KW; Yan DC
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
[TBL] [Abstract][Full Text] [Related]
16. CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms.
Scalzo-Inguanti K; Plebanski M
Eur J Immunol; 2011 May; 41(5):1298-308. PubMed ID: 21469087
[TBL] [Abstract][Full Text] [Related]
17. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.
Sharma S; Wang J; Huang M; Paul RW; Lee P; McBride WH; Economou JS; Roth MD; Kiertscher SM; Dubinett SM
Cancer Gene Ther; 1996; 3(5):302-13. PubMed ID: 8894249
[TBL] [Abstract][Full Text] [Related]
19. Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy.
Montes M; Rufer N; Appay V; Reynard S; Pittet MJ; Speiser DE; Guillaume P; Cerottini JC; Romero P; Leyvraz S
Clin Exp Immunol; 2005 Nov; 142(2):292-302. PubMed ID: 16232216
[TBL] [Abstract][Full Text] [Related]
20. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
